Survivin 2α: a novel Survivin splice variant expressed in human malignancies
Open Access
- 2 March 2005
- journal article
- Published by Springer Nature in Molecular Cancer
- Vol. 4 (1) , 1-11
Abstract
Background: Survivin and its alternative splice forms are involved in critical cellular processes, including cell division and programmed cell death. Survivin is expressed in the majority of human cancers, but minimally in differentiated normal tissues. Expression levels correlate with tumor aggressiveness and resistance to therapy. Results: In the present study, we identify and characterize a novel survivin isoform that we designate survivin 2α. Structurally, the transcript consists of 2 exons: exon 1 and exon 2, as well as a 3' 197 bp region of intron 2. Acquisition of a new in-frame stop codon within intron 2 results in an open reading frame of 225 nucleotides, predicting a truncated 74 amino acid protein. Survivin 2α is expressed at high levels in several malignant cell lines and primary tumors. Functional assays show that survivin 2α attenuates the anti-apoptotic activity of survivin. Subcellular localization and immunoprecipitation of survivin 2α suggests a physical interaction with survivin. Conclusion: We characterized a novel survivin splice variant that we designated survivin 2α. We hypothesize that survivin 2α can alter the anti-apoptotic functions of survivin in malignant cells. Thus survivin 2α may be useful as a therapeutic tool in sensitizing chemoresistant tumor cells to chemotherapy.Keywords
This publication has 20 references indexed in Scilit:
- An alternatively spliced survivin variant is positively regulated by p53 and sensitizes leukemia cells to chemotherapyOncogene, 2004
- Identification of a novel splice variant of the human anti-apoptopsis gene survivinBiochemical and Biophysical Research Communications, 2004
- Survivin is required for stable checkpoint activation in taxol-treated HeLa cellsJournal of Cell Science, 2003
- The complex life of WT1Journal of Cell Science, 2003
- The antiapoptosis protein survivin is associated with cell cycle entry of normal cord blood CD34+ cells and modulates cell cycle and proliferation of mouse hematopoietic progenitor cellsBlood, 2002
- Human Survivin Is a Kinetochore-Associated Passenger ProteinJournal of Cell Biology, 2000
- The inhibitors of apoptosis (IAPs) and their emerging role in cancerOncogene, 1998
- Induction of Apoptosis and Inhibition of Cell Proliferation bysurvivin Gene TargetingJournal of Biological Chemistry, 1998
- Anti-apoptosis gene, survivin, and prognosis of neuroblastomaThe Lancet, 1998
- Characterization of new human c-myc mRNA species produced by alternative splicingGene, 1996